Konstantinos Boudoulas, MD
Interventional Cardiology · Columbus, OHNPI 1003976507
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,186 of the $2,463 with a category attached, or 88.7%. Ancora Heart, Inc. accounts for 88.7% of it on its own, with 3 other manufacturers making up the rest. 2021 is the largest year on record at $2,186, 8.4 times the $259 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in OH, where the typical reported total is $4,547.
Across 8 payments — averaging $307.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ancora Heart, Inc.$2K
- Abbott$149
- Corindus Inc.$109
- Medtronic$18
Across 157 payments — averaging $2550.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$148K
- Edwards Lifesciences$138K
- Medtronic$112K
- Philips North America LLC$2K
What the payments were for
- Travel & lodging$2,18689%
- Food & beverage$27711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ancora Heart, Inc. | 5 | $2,186 |
| Abbott | 1 | $149 |
| Corindus Inc. | 1 | $109 |
| Medtronic | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AccuCinch$2,186
- Mitra Clip system$149
- CorPath GRX$109
How this compares
$2,463 in reported general payments places this provider in the 35th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 14 | $207 |
| ClopidogrelClopidogrel Bisulfate | 16 | $103 |
| Carvedilol | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- Michael JollyColumbus$281K
- Timothy SmithColumbus$149K
- Christopher HuffColumbus$119K
- Joseph CampbellColumbus$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.